Abstract
The convergence of nanoscience and nucleotide delivery holds tremendous
promise in revolutionizing diabetes treatment. Nucleotide delivery emerged as a
promising tool to modulate gene expression and cellular function in diabetes.
Integration of nanoscience and nucleotide delivery in diabetes treatment opens avenues
for efficient therapies. This approach has the potential to significantly improve glucose
regulation and mitigate long-term complications associated with the disease. This
chapter discussed DNA and RNA delivery approaches in diabetes treatment and the
future and challenges of nucleotide delivery in diabetes.